Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-014086
Filing Date
2025-05-01
Accepted
2025-05-01 16:04:56
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opk20250331_10q.htm   iXBRL 10-Q 1870711
2 EXHIBIT 10.1 ex_807263.htm EX-10.1 56635
3 EXHIBIT 31.1 ex_792607.htm EX-31.1 12382
4 EXHIBIT 31.2 ex_792608.htm EX-31.2 12304
5 EXHIBIT 32.1 ex_792609.htm EX-32.1 3885
6 EXHIBIT 32.2 ex_792610.htm EX-32.2 3790
  Complete submission text file 0001437749-25-014086.txt   11094848

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA opk-20250331.xsd EX-101.SCH 93045
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20250331_cal.xml EX-101.CAL 69137
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20250331_def.xml EX-101.DEF 722410
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20250331_lab.xml EX-101.LAB 572030
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20250331_pre.xml EX-101.PRE 752775
95 EXTRACTED XBRL INSTANCE DOCUMENT opk20250331_10q_htm.xml XML 1876034
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 25902946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)